Literature DB >> 30711069

Association between Disability, Cognition, Fatigue, EQ-5D-3L Domains, and Utilities Estimated with Different Western European Value Sets in Patients with Multiple Sclerosis.

Jennifer Eriksson1, Gisela Kobelt2, Mia Gannedahl3, Jenny Berg3.   

Abstract

OBJECTIVES: To assess the association between fatigue, cognition, domains of the EuroQol five-dimensional questionnaire (EQ-5D-3L), disability, and utilities estimated with several Western European value sets in patients with multiple sclerosis (MS).
METHODS: Data from a multinational, cross-sectional, observational study of patients with MS (N = 16,808) conducted in 16 European countries were used. Health-related quality of life data were collected through the EQ-5D-3L, and fatigue and cognitive difficulties were self-assessed on a 10-point visual analogue scale. Associations were assessed using Pearson correlation and multivariate regression model.
RESULTS: Symptoms of fatigue and cognitive difficulties were present in 90% and 70% of patients at all levels of disability, respectively, and thus only weakly correlated to disability. Problems in the EQ-5D-3L domains were common even at mild disability levels. Mobility, usual activities, and pain issues were experienced by 80% to 90% of patients with moderate and high levels of disability. Mobility, usual activities, and self-care were strongly correlated to disability. Disability, MS type, fatigue, and cognition were associated with utility in regression models, although the coefficients of fatigue and cognition were small.
CONCLUSIONS: The strong relationship of disability with utility was confirmed. Despite this, fatigue and cognitive difficulties were associated with utility estimated with different European value sets.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D-3L; cognition; disability; fatigue; multiple sclerosis; utility values.

Mesh:

Year:  2018        PMID: 30711069     DOI: 10.1016/j.jval.2018.08.002

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  3 in total

1.  Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors.

Authors:  Sapir Dreyer-Alster; Shay Menascu; Roy Aloni; Uri Givon; Mark Dolev; Anat Achiron; Alon Kalron
Journal:  Ther Adv Neurol Disord       Date:  2022-07-04       Impact factor: 6.430

2.  Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS).

Authors:  Georgios Tsivgoulis; Spyros Deftereos; Claudio Gobbi; Elisabeth Gulowsen Celius; Alina Kulakowska; Giorgia Maniscalco; Irene Mendes; Nicolaos Grigoriadis
Journal:  J Cent Nerv Syst Dis       Date:  2022-04-01

3.  Fatigue, Depression, and Anxiety Among Ambulating Multiple Sclerosis Patients.

Authors:  Safanah AlSaeed; Tamadher Aljouee; Nuha M Alkhawajah; Rola Alarieh; Hanan AlGarni; Salman Aljarallah; Mohsen Ayyash; Amani Abu-Shaheen
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.